End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0158 USD | +6.76% |
|
-9.71% | -25.82% |
05-06 | Curative Biotechnology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Curative Biotechnology, Inc. has withdrawn its IPO in the amount of $7.999998 million. | CI |
Business Summary
Number of employees: 4
Managers
Managers | Title | Age | Since |
---|---|---|---|
I. Garr
CEO | Chief Executive Officer | 71 | 21-02-10 |
Paul M. Michael
CHM | Chairman | - | - |
Steve Chizzik
IRC | Investor Relations Contact | - | - |
Ron Bordens
PRN | Corporate Officer/Principal | - | 21-02-10 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Cary Sucoff
BRD | Director/Board Member | 71 | 22-05-11 |
Theresa Heah
BRD | Director/Board Member | 46 | 03-30 |
Lawrence Zaslow
BRD | Director/Board Member | - | - |
Paul M. Michael
CHM | Chairman | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 227,000 | 0 | 0 | 99.94 % |
Stock B | 1 | 903,263,385 | 902,756,978 ( 99.94 %) | 0 | |
Stock C | 0 | 30,000,000 | 0 | 0 |
Company contact information
Curative Biotechnology, Inc.
3801 PGA Boulevard Suite 600
33410, Palm Beach Gardens
+
http://www.curativebiotech.com![address Curative Biotechnology, Inc.(CUBT)](https://cdn.zonebourse.com/static/address/120790750.png)
Sector
1st Jan change | Capi. | |
---|---|---|
-25.82% | 13.37M | |
+38.36% | 52.5B | |
+36.73% | 39.31B | |
-8.63% | 39.01B | |
+25.46% | 28.2B | |
-11.17% | 26.57B | |
+11.44% | 26.2B | |
+45.09% | 14.15B | |
+32.93% | 12.62B | |
-5.30% | 11.74B |
- Stock Market
- Equities
- CUBT Stock
- Company Curative Biotechnology, Inc.